Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label attachment file name title
tabling member	label

Search

647740

registered interest
date	29/11/2016
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Tobacco
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, when he plans to publish a new tobacco control plan.
tabling member constituency	Monmouth
tabling member printed	David T. C. Davies
uin	55414
answer	answer is ministerial correction date of answer 06/12/2016 answer text <p>The Government is developing a new tobacco control plan, which will build on previous success and will be published shortly.</p> answering member constituency Oxford West and Abingdon answering member printed Nicola Blackwood question first answered 06/12/2016 12:09:05 answering member 4019 label Biography information for Baroness Blackwood of North Oxford
tabling member	1545 label Biography information for David T C Davies

348998

registered interest
date	08/06/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	NHS England: Compensation
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, how much NHS England has paid in compensation to patients in each of the last three years for which figures are available.
tabling member constituency	Monmouth
tabling member printed	David T. C. Davies
uin	1380
answer	answer is ministerial correction date of answer 16/06/2015 answer text <p>The NHS Litigation Authority (NHS LA) indemnifies National Health Service organisations in England and many independent sector providers of NHS care against claims.</p><p> </p><p> </p><p> </p><p>The NHS LA handles clinical negligence claims on behalf of its members under the Clinical Negligence Scheme for Trusts (CNST). Currently, all NHS trusts in England are members of the CNST.</p><p> </p><p> </p><p> </p><p>The amounts paid by the NHS LA to patients under CNST in the last three years where NHS England is the legal defendant are contained in the table below:</p><p> </p><p><strong> </strong></p><p> </p><table><tbody><tr><td><p>Payment</p><p>Year</p></td><td><p>Damages</p><p>Paid</p></td><td><p>Defence Costs</p><p>Paid</p></td><td><p>Claimant Costs</p><p>Paid</p></td><td><p>Total Amount</p><p>Paid</p></td></tr><tr><td><p>2011/12</p></td><td><p>£787,905</p></td><td><p>£308,479</p></td><td><p>£1,144,361</p></td><td><p>£2,240,745</p></td></tr><tr><td><p>2012/13</p></td><td><p>£6,015,035</p></td><td><p>£646,217</p></td><td><p>£1,406,681</p></td><td><p>£8,067,933</p></td></tr><tr><td><p>2013/14</p></td><td><p>£4,428,933</p></td><td><p>£981,496</p></td><td><p>£3,330,594</p></td><td><p>£8,741,022</p></td></tr></tbody></table><p> </p><p><em> </em></p><p> </p><p><em>Source: </em>NHS LA</p><p> </p> answering member constituency Ipswich answering member printed Ben Gummer question first answered 16/06/2015 16:20:19 answering member 3988 label Biography information for Ben Gummer
tabling member	1545 label Biography information for David T C Davies

171484

registered interest
date	18/12/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Tattooing
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, how many patients have had tattoos removed on the NHS in each of the last three financial years.
tabling member constituency	Monmouth
tabling member printed	David T. C. Davies
uin	219362
answer	answer is ministerial correction date of answer 09/01/2015 answer text <p>The information is not held. Cosmetic procedures are not usually available through the National Health Service.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 09/01/2015 14:24:25 answering member 3918 label Biography information for Jane Ellison
tabling member	1545 label Biography information for David T C Davies

171485

registered interest
date	18/12/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Breasts: Plastic Surgery
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, how many patients have had breast enhancement surgery for cosmetic or non medical reasons in each of the last three years.
tabling member constituency	Monmouth
tabling member printed	David T. C. Davies
uin	219363
answer	answer is ministerial correction date of answer 09/01/2015 answer text <p>This information is not held. Cosmetic surgery is not usually available through the National Health Service.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 09/01/2015 13:39:26 answering member 3918 label Biography information for Jane Ellison
tabling member	1545 label Biography information for David T C Davies

167069

registered interest
date	01/12/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, whether he plans to apply standardised packaging of tobacco to legal high products.
tabling member constituency	Monmouth
tabling member printed	David T. C. Davies
uin	216500
answer	answer is ministerial correction date of answer 08/12/2014 answer text <p>The Government’s proposals for standardised packaging of tobacco products were set out in the consultation that was published on 26 June 2014. That consultation included draft regulations which specified requirements for the packaging of cigarettes and hand-rolling tobacco only.</p><p> </p><p> </p><p> </p><p>The consultation document entitled <em>Consultation on the introduction of regulations for standardised packaging of tobacco products,</em> has been attached.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison grouped question UIN 216501 question first answered 08/12/2014 15:13:51 answering member 3918 label Biography information for Jane Ellison attachment 1 file name Consultation on the introduction of regulations for standardised packaging of tobacco products.pdf title Consultation on Regulations Standardised Packaging
tabling member	1545 label Biography information for David T C Davies

167070

registered interest
date	01/12/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Electronic Cigarettes
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, whether he plans to apply standardised packaging of tobacco to e-cigarettes.
tabling member constituency	Monmouth
tabling member printed	David T. C. Davies
uin	216501
answer	answer is ministerial correction date of answer 08/12/2014 answer text <p>The Government’s proposals for standardised packaging of tobacco products were set out in the consultation that was published on 26 June 2014. That consultation included draft regulations which specified requirements for the packaging of cigarettes and hand-rolling tobacco only.</p><p> </p><p> </p><p> </p><p>The consultation document entitled <em>Consultation on the introduction of regulations for standardised packaging of tobacco products,</em> has been attached.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison grouped question UIN 216500 question first answered 08/12/2014 15:13:51 answering member 3918 label Biography information for Jane Ellison attachment 1 file name Consultation on the introduction of regulations for standardised packaging of tobacco products.pdf title Consultation on Regulations Standardised Packaging
tabling member	1545 label Biography information for David T C Davies

93017

registered interest
date	13/10/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Electronic Cigarettes
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what the implications are for his policy of the statement by the Chief Medical Officer that e-cigarettes represent one of the three major health threats to the UK.
tabling member constituency	Monmouth
tabling member printed	David T. C. Davies
uin	210193
answer	answer is ministerial correction date of answer 16/10/2014 answer text <p>The Government’s policy on e-cigarettes is to enable the availability of products which meet appropriate standards of safety, quality and efficacy to support smoking cessation and to reduce the harm of smoking to smokers and those around them.</p><p> </p><p> </p><p> </p><p>Beyond licenced medicinal products, the Government is working to transpose the provision of the Tobacco Products Directive (Directive 2014/40/EU) which will provide a framework for e-cigarettes which are not licensed as medicines. In addition to the safeguards the Tobacco Products Directive will introduce, the Government is committed to banning the sale of e-cigarettes to under 18s to protect children from the potential for nicotine addiction and the unknown risks of using e-cigarettes to developing lungs.</p><p> </p><p> </p><p> </p><p>The Government’s policy will remain evidence based and we will continue to closely monitor all emerging research.</p><p> </p><p><strong> </strong></p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 16/10/2014 15:13:08 answering member 3918 label Biography information for Jane Ellison
tabling member	1545 label Biography information for David T C Davies

92255

registered interest
date	26/09/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Smoking
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, how many adverse drug reaction reports have been received relating to the use of (a) nicotine replacement therapies, (b) varenicline and (c) e-cigarettes by school children.
tabling member constituency	Monmouth
tabling member printed	David T. C. Davies
uin	209711
answer	answer is ministerial correction date of answer 15/10/2014 answer text <p>Reports of suspected adverse drug reactions (ADRs) are collected by the Medicines and Healthcare products Regulatory Agency (MHRA) and Commission for Human Medicines through the spontaneous reporting scheme, the Yellow Card Scheme. The scheme collects ADR reports from across the United Kingdom and includes all medicines, including those from prescriptions, those bought over-the-counter in pharmacies or general retail sales outlets. Reports are also received for herbal medicines and other unlicensed medicines.</p><p> </p><p> </p><p> </p><p>The table below shows the total number of UK spontaneous ‘suspected’ ADR reports in association with school children (ages 5-16), received by the MHRA up to 30 September 2014 broken down for E-Cigarettes, Nicotine Replacement Therapies (excluding E-Cigarettes) and Varenicline.</p><p> </p><p> </p><p> </p><table><tbody><tr><td><p> </p></td><td><p>Total Number of Reports</p></td></tr><tr><td><p>Varenicline</p></td><td><p>3</p></td></tr><tr><td><p>Nicotine Replacement therapy</p></td><td><p>8</p></td></tr><tr><td><p>E-Cigarettes</p></td><td><p>0</p></td></tr></tbody></table><p> </p><p> </p><p> </p><p>There is unknown and variable level of under-reporting to the Yellow Card Scheme meaning that data collected cannot be used to calculate incidence. We are unable to calculate this incidence because neither the total number of reactions occurring in the population, nor the number of patients using the drug is known.</p><p> </p><p> </p><p> </p><p>The MHRA does not hold data on the number of fatalities associated with nicotine replacement therapies varenicline or e-cigarettes in other countries.</p><p> </p><p> </p><p> </p><p>The requirements for medicines labelling and patient information are set out in European and national legislation. Provisions already exist for a series of warning statements to appear on the packs of nicotine replacement therapy medicines. All medicines are also accompanied by a patient information leaflet which includes detailed information on the safe and effective use of the product and warnings about known adverse effects.</p><p> </p><p> </p><p> </p> answering member constituency Battersea answering member printed Jane Ellison grouped question UIN 209710 209716 question first answered 15/10/2014 16:27:32 answering member 3918 label Biography information for Jane Ellison
tabling member	1545 label Biography information for David T C Davies

92256

registered interest
date	26/09/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Smoking
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what information his Department holds on how many fatalities have been reported in other countries arising from the use of (a) nicotine replacement therapies, (b) varenicline and (c) e-cigarettes.
tabling member constituency	Monmouth
tabling member printed	David T. C. Davies
uin	209710
answer	answer is ministerial correction date of answer 15/10/2014 answer text <p>Reports of suspected adverse drug reactions (ADRs) are collected by the Medicines and Healthcare products Regulatory Agency (MHRA) and Commission for Human Medicines through the spontaneous reporting scheme, the Yellow Card Scheme. The scheme collects ADR reports from across the United Kingdom and includes all medicines, including those from prescriptions, those bought over-the-counter in pharmacies or general retail sales outlets. Reports are also received for herbal medicines and other unlicensed medicines.</p><p> </p><p> </p><p> </p><p>The table below shows the total number of UK spontaneous ‘suspected’ ADR reports in association with school children (ages 5-16), received by the MHRA up to 30 September 2014 broken down for E-Cigarettes, Nicotine Replacement Therapies (excluding E-Cigarettes) and Varenicline.</p><p> </p><p> </p><p> </p><table><tbody><tr><td><p> </p></td><td><p>Total Number of Reports</p></td></tr><tr><td><p>Varenicline</p></td><td><p>3</p></td></tr><tr><td><p>Nicotine Replacement therapy</p></td><td><p>8</p></td></tr><tr><td><p>E-Cigarettes</p></td><td><p>0</p></td></tr></tbody></table><p> </p><p> </p><p> </p><p>There is unknown and variable level of under-reporting to the Yellow Card Scheme meaning that data collected cannot be used to calculate incidence. We are unable to calculate this incidence because neither the total number of reactions occurring in the population, nor the number of patients using the drug is known.</p><p> </p><p> </p><p> </p><p>The MHRA does not hold data on the number of fatalities associated with nicotine replacement therapies varenicline or e-cigarettes in other countries.</p><p> </p><p> </p><p> </p><p>The requirements for medicines labelling and patient information are set out in European and national legislation. Provisions already exist for a series of warning statements to appear on the packs of nicotine replacement therapy medicines. All medicines are also accompanied by a patient information leaflet which includes detailed information on the safe and effective use of the product and warnings about known adverse effects.</p><p> </p><p> </p><p> </p> answering member constituency Battersea answering member printed Jane Ellison grouped question UIN 209711 209716 question first answered 15/10/2014 16:27:32 answering member 3918 label Biography information for Jane Ellison
tabling member	1545 label Biography information for David T C Davies

92259

registered interest
date	26/09/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Electronic Cigarettes
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what assessment he has made of progress by the British Standards Institute towards the creation of a publicly available specification for e-cigarettes.
tabling member constituency	Monmouth
tabling member printed	David T. C. Davies
uin	209746
answer	answer is ministerial correction date of answer 15/10/2014 answer text <p>The Department has not undertaken an assessment of work on developing best practice standards by the British Standards Institute.</p><p> </p><p> </p><p> </p><p>The revised Tobacco Products Directive (Directive 2014/40/EU), which will enter into force from May 2016, will ensure a high level of health protection for United Kingdom citizens. It will introduce a new system of regulation for e-cigarettes and the continued availability of products that meet the regulatory requirements. We will consult, in due course, on plans for implementation.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 15/10/2014 14:26:04 answering member 3918 label Biography information for Jane Ellison
tabling member	1545 label Biography information for David T C Davies